IoMT in Healthcare: The Move to Continuous, Data-Driven Care

13 May 2026.

IoMT is reshaping healthcare through AI, wearables and connected care.

The New Defence Constraint: Not Demand, But Delivery

8 May 2026.

Defence demand rises, but delivery capacity now defines competitive advantage

Beyond the Batch: Pharma Manufacturing Becomes Strategic

6 May 2026.

CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing

Defence at Pace: Naval Readiness Tests Industrial Capacity

1 May 2026.

Defence readiness now depends on resilient supply chains and scalable delivery

Pharmaceutical Packaging Moves Up the Value Chain

29 April 2026.

Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical

Defence at Scale: Production Constraints Reshaping Global Capability Delivery

24 April 2026.

Defence demand rising, but execution and production capacity constrain delivery

UDT 2026: What Matters Now and What it Means for AUKUS

17 April 2026.

UDT 2026 highlights shift to undersea capability delivery and integration

UDT 2026 Day Three: From Concept to Capability in Undersea Warfare

16 April 2026.

Undersea defence shifts from concept to deployable, integrated capability

Undersea Defence Technology (UDT) 2026: Day Two Highlights

15 April 2026.

UDT 2026 day two: speed, autonomy and AUKUS shape defence

UDT 2026 Day Two Live Update: Maritime and Undersea Risks Intensify

15 April 2026.

UDT 2026 update: maritime conflict reshapes undersea defence priorities

UK Defence: Sovereignty, Scale and the Pressure to Deliver

10 April 2026.

UK defence demand rises; infrastructure protection, AI, undersea capability drive challenges

Air Defence Demand Surges, Outpacing Production Capacity

3 April 2026.

Conflict-driven demand surges expose defence production limits and supply constraints

The Race to Own Alzheimer’s: New Therapies Reshape Market

1 April 2026.

Alzheimer’s shifts to early intervention, with innovation reshaping competitive dynamics.

Global Defence: Drones, Interceptors and Stockpiles

27 March 2026.

Production limits, drone threats, and supply chains reshape defence priorities.

Decentralised Clinical Trials: From Adoption to Execution Risk

25 March 2026.

Decentralised trials shift from adoption to execution as complexity rises

Rheumatoid Arthritis Is Entering a New Competitive Phase

18 March 2026.

RA market shifting beyond biologics, driven by access, innovation, and pricing

The GLP-1 Boom: A Drug Class Redefining the Obesity Market

13 March 2026.

GLP-1 therapies are transforming obesity treatment and reshaping the global pharmaceutical market

How the Middle East Is Exposing Defence Production Limits

6 March 2026.

Middle East missile campaigns expose interceptor shortages and accelerate missile defence production investment.

Precision Payloads: The Rise of Antibody Drug Conjugates in Modern Oncology

4 March 2026.

Antibody drug conjugates are reshaping oncology through precision targeting, expanding pipelines and industry partnerships

Procurement: Sovereignty Is Rewriting the Rules

27 February 2026.

Defence spending rises, but industrial alignment now decides contract winners.

Clients & Partners

BP logo Kelloggs logo BAE systems logo Unilever logo BASF logo 3M logo THALES logo TEVA logo Shell logo Raytheon logo Pfizer logo Lockhead Martin logo Mercedes logo Honeywell logo DUPONT logo Daimler logo Deloitte logo